This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Adient (ADNT) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Will Adient (ADNT) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Adient (ADNT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Is Westport (WPRT) Up 3.2% Since Last Earnings Report?
by Zacks Equity Research
Westport (WPRT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Adient (ADNT) Soars 6.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Adient (ADNT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Adient (ADNT) Up 14% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Do Options Traders Know Something About Adient Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to ADNT stock based on the movements in the options market lately.
5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost
by Maharathi Basu
Broker-favored picks like BYON, BTSG, ACDVF, EBS, and ADNT are worth monitoring amid EU tariff delay and rising consumer confidence.
Here's Why You Should Retain Adient Stock in Your Portfolio Now
by Zacks Equity Research
ADNT is poised to gain from its broad range of products and frequent business wins despite headwinds from higher restructuring costs in Europe.
Adient Q2 Earnings Surpass Expectations, FCF View Lowered
by Zacks Equity Research
ADNT reports better-than-expected Q2 results and expects 2025 free cash flow in the range of $150-$170 million, down from the previous estimate of $180 million.
Adient (ADNT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Adient (ADNT) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Adient (ADNT) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 91.67% and 4.07%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Adient Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to ADNT stock based on the movements in the options market lately.
Garrett Motion (GTX) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Garrett Motion (GTX) delivered earnings and revenue surprises of 3.45% and 4.15%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Adient (ADNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in Ferrari (RACE): Can Its 3.2% Jump Turn into More Strength?
by Zacks Equity Research
Ferrari (RACE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks Industry Outlook Highlights American Axle & Manufacturing, Allison Transmission and Adient
by Zacks Equity Research
American Axle & Manufacturing, Allison Transmission and Adient are part of the Zacks Industry Outlook article.
3 Original Auto Equipment Stocks to Consider Amid High Tariffs
by Lavina Shahu
Amid tariff-related uncertainty, auto equipment stocks like AXL, ALSN & ADNT are set to gain from their expanding footprints, acquisitions and continued innovation.
Do Options Traders Know Something About Adient (ADNT) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Adient (ADNT) stock based on the movements in the options market lately.
Adient (ADNT) Down 7.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for February 20th
by Zacks Equity Research
ASGN, ADNT and AFG have been added to the Zacks Rank #5 (Strong Sell) List on February 20, 2024.
New Strong Sell Stocks for February 10th
by Zacks Equity Research
ASGN, AHEXY and ADNT have been added to the Zacks Rank #5 (Strong Sell) List on February 10, 2025.
New Strong Sell Stocks for February 6th
by Zacks Equity Research
ADNT, AOS and BASFY have been added to the Zacks Rank #5 (Strong Sell) List on February 6, 2025.
Adient Q1 Earnings Surpass Expectations, FY25 Sales View Cut
by Zacks Equity Research
ADNT reports better-than-expected fiscal Q1 results. It expects fiscal 2025 revenues to be $13.9 billion, down from the previous estimate of $14.1-$14.4 billion.
Adient (ADNT) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 12.50% and 2%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Best Value Stocks to Buy for January 21st
by Zacks Equity Research
NGVT, ICL and ADNT made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 21, 2025.